MBLY revenue +0.4% YoY as operating loss narrows 59%; $3.8B goodwill impairment taken in Q1

Filed July 23, 2026 · Period ending June 27, 2026 · Compared to 10-Q Jul 24, 2025 · ~2 min read

Key Changes

• high

  Company recorded $3.8B non-cash goodwill impairment in Q1 FY26, triggered by 35% share-price decline, heightened Israel-Iran conflict risk, and increased discount rate. MD&A notes 1% higher discount rate or 0.5% lower terminal growth would have added $682M and $141M impairment, respectively.

  MD&A: Goodwill Impairment verify on EDGAR →
• high

  Acquired Mentee Robotics (Feb 2026) to enter humanoid robotics market and announced plans (Jun 2026) to own/operate a robotaxi service, moving beyond technology supply. Both initiatives are in initial stages and may require significant capital, management attention, and involve commercialization uncertainties.

  MD&A: Strategic Expansion verify on EDGAR →
• high

  Israel R&D Law enacted Mar 2026 provides refundable tax credit for qualifying R&D spend. Company recognized $17M grant in Q2 FY26 covering H1 2026, reducing R&D expenses. Incentive may be offset against Israeli taxes or received as cash after carryforward period.

  MD&A: R&D Law Incentive verify on EDGAR →